Treace Medical Concepts (TMC) Compression Implant System

K232387 · Treace Medical Concepts · JDR · Aug 28, 2023 · Orthopedic

Device Facts

• Record ID: K232387
• Device Name: Treace Medical Concepts (TMC) Compression Implant System
• Applicant: Treace Medical Concepts
• Product Code: JDR · Orthopedic
• Decision Date: Aug 28, 2023
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 888.3030
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The system is intended to be used for fracture fixation, osteotomy fixation, and joint arthrodesis of the foot and ankle.

Device Story

TMC Compression Implant System consists of metallic bone staples and associated instrumentation for foot and ankle surgery. Implants are used for fracture fixation, osteotomy fixation, and joint arthrodesis. System includes various bridge lengths, leg lengths, and cross-sections (2x2 and 4x1 leg configurations). Implants are implanted by surgeons in clinical settings to provide bone stabilization. Modifications include updated bridge geometry, leg diameter, leg length, and leg profile. Implants are manufactured from titanium alloy and provided sterile. Device provides mechanical compression across bone segments to facilitate healing.

Clinical Evidence

Bench testing only. Mechanical performance (bending and pull-out) evaluated per ASTM F564-17 Standard Specification and Test Methods for Metallic Bone Staples. Testing demonstrated subject device met all acceptance criteria compared to predicate Z-Medical Z-Staple.

Technological Characteristics

Metallic bone staples; material: Ti-6Al-4V-ELI titanium alloy per ASTM F136; sterilization: gamma irradiation; design: 2x2 and 4x1 leg configurations; mechanical testing per ASTM F564-17.

Indications for Use

Indicated for patients requiring fracture fixation, osteotomy fixation, or joint arthrodesis of the foot and ankle.

Regulatory Classification

Identification

Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.

Predicate Devices

• TMC Compression Implant System (K222645)
• Z-Medical Z-Staple (K121277)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo features the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.

August 28, 2023

Treace Medical Concepts Brittany Grochala Sr. Regulatory Affairs Specialist 100 Palmetto Park Place Ponte Vedra, Florida 32081

Re: K232387

Trade/Device Name: Treace Medical Concepts (TMC) Compression Implant System Regulation Number: 21 CFR 888.3030 Regulation Name: Single/Multiple Component Metallic Bone Fixation Appliances And Accessories Regulatory Class: Class II Product Code: JDR Dated: August 8, 2023 Received: August 9, 2023

Dear Brittany Grochala:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's

{1}------------------------------------------------

requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

# Limin Sun -S

Limin Sun, Ph.D. Assistant Director DHT6A: Division of Joint Arthroplasty Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

# Indications for Use

510(k) Number (if known) K232387

Device Name

Treace Medical Concepts (TMC) Compression Implant System

Indications for Use (Describe)

The system is intended to be used for fracture fixation, osteotomy fixation, and joint arthrodesis of the foot and ankle.

Type of Use (Select one or both, as applicable)

X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

Image /page/3/Picture/0 description: The image is a logo for Treace Medical Concepts, Inc. The logo features the word "TREACE" in gray, with a red swoosh above the "A". Below the word "TREACE" is the text "Medical Concepts, Inc." in gray. Below that is the text "The Leader in Hallux Valgus Surgery" in red.

# 510(k) Summary Treace Medical Concepts (TMC) Compression Implant System August 08, 2023

| Company: | Treace Medical Concepts, Inc.<br>100 Palmetto Park Place<br>Ponte Vedra, FL 32081 |
|-----------------------------|---------------------------------------------------------------------------------------------------------------------------------|
| Establishment Registration: | 3011623994 |
| Primary Contact: | Brittany Grochala, Sr. Regulatory Affairs Specialist<br>Phone: [phone]<br>Fax: [phone]<br>Email: [e-mail] |
| Secondary Contact: | Kristina Hall, Director, Regulatory Affairs<br>Phone: [phone] ext. 1321<br>Fax: [phone]<br>Email: [e-mail] |
| Trade Name: | Treace Medical Concepts (TMC) Compression Implant<br>System |
| Common Name: | Staple, fixation, bone |
| Classification: | Class II |
| Regulation Number: | 21 CFR 888.3030 Single/multiple component metallic bone<br>fixation appliances and accessories |
| Panel: | 87- Orthopedic |
| Product Code(s): | Primary: JDR |

## Predicate Device(s):

Primary Predicate:

- TMC Compression Implant System (K222645, S.E. 11/21/2022) .
Additional Predicate:

- Z-Medical Z-Staple (K121277, S.E. 11/07/2012) .
### Device Description:

The TMC Compression Implant System consists of implants and related instrumentation for implantation. The implants are offered in multiple combinations of bridge lengths, leg lengths, and cross sections to accommodate various anatomies. This includes two (2x2, 4x1) legged implants. The system is intended to be used for fracture fixation, osteotomy fixation, and joint arthrodesis of the foot and ankle.

The purpose of this Special 510(k) submission is to expand the implant and instrument options for the TMC Compression Implant System. The subject implants and instruments are modifications of the previously cleared TMC Compression Implant System (K222645).

{4}------------------------------------------------

Image /page/4/Picture/0 description: The image is a logo for TREACE Medical Concepts, Inc. The logo is in gray, except for a red swoosh above the letters A and C. Below the company name is the tagline "The Leader in Hallux Valgus Surgery" in red.

All implantable components are manufactured from implant grade titanium alloy (Ti-6AI-4V-ELI) per ASTM F136 and are provided sterile by gamma irradiation.

## Indications for Use:

The system is intended to be used for fracture fixation, osteotomy fixation, and joint arthrodesis of the foot and ankle.

### Substantial Equivalence:

The subject TMC Compression Implant System is substantially equivalent to the following predicate devices:

Primary Predicate:

- TMC Compression Implant System (K222645, S.E. 11/21/2022) .
Additional Predicate:

- Z-Medical Z-Staple (K121277, S.E. 11/07/2012) .
The subject compression implants are intended to be used for fracture fixation, osteotomy fixation, and joint arthrodesis of the foot and ankle, identical or equivalent to the predicate devices. The subject compression implants are manufactured from implant grade titanium alloy (Ti-6Al-4V-ELI) per ASTM F136, identical to the predicate devices.

The subject device modifications include updates to the implant bridge geometry, leg diameter, leg length. leg profile, and an anatomic leg location design (4x1 implant only). The subject 2x1 and 4x1 compression implants include thinner bridges and the subject 4x1 implants have shorter legs as compared to the primary predicate. The subject 2x1 implants have larger leg diameters while the leg lengths remain unchanged as compared to the primary predicate.

The subject implants were compared to the additional predicate per ASTM F564-17 Standard Specification and Test Methods for Metallic Bone Staples. Mechanical testing including bending and pull-out performance have been completed to evaluate the subject device against the additional predicate device. These are the same well-established methods utilized in the original, primary predicate TMC Compression Implant System submission (K222645). The testing demonstrated that the subject device met all acceptance criteria.

The subject devices share similar materials, geometry, construction, packaging, overall design, and performance with the predicate devices. Thus, it can be concluded that the subject devices do not raise new questions about safety and effectiveness and are substantially equivalent to the predicate devices.

### Performance Testing:

The subject devices were compared to the predicate device, Z-Medical Z-Staples, in bending performance and pullout performance testing per ASTM F564 Standard Specification and Test Methods for Bone Metallic Staples. The testing demonstrated that the subject device met all acceptance criteria. Therefore, the subject device is substantially equivalent to the predicate device.

{5}------------------------------------------------

Image /page/5/Picture/0 description: The image is a logo for Treace Medical Concepts, Inc. The logo is in gray, except for a red swoosh above the letters 'ACE'. Below the logo is the text 'Medical Concepts, Inc.' in gray. Below that, in red, is the text 'The Leader in Hallux Valgus Surgery'.

TMC Compression Implant System Special 510(k) Premarket Notification K232387 Page 3

# Conclusion:

The subject TMC Compression Implant System has similar intended use, overall design, materials, and mechanical properties to that of the predicate devices. Moreover, there is no change in the intended use as compared to the predicate TMC Compression Implant System. Therefore, it can be concluded that the subject device is at least as safe and effective and substantially equivalent to the predicate devices.